MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO

The present invention relates to 4-[6-(6¬methanesulfonyl-2-methyl-pyridin-3-ylamino)-5¬methyl-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester, pharmaceutically acceptable salts, solvates and hydrates thereof that are modulators of glucose metabolism. Accordingly, compounds of the pre...

Full description

Saved in:
Bibliographic Details
Main Authors JONES,ROBERT M, LEHMANN,JUERG
Format Patent
LanguageEnglish
Published 14.04.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to 4-[6-(6¬methanesulfonyl-2-methyl-pyridin-3-ylamino)-5¬methyl-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester, pharmaceutically acceptable salts, solvates and hydrates thereof that are modulators of glucose metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as diabetes and obesity.
Bibliography:Application Number: TN2008SN00534